Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Vir Biotechnology Q4 Earnings

Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
February 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Vir Biotechnology beat estimated earnings by 28.95%, reporting an EPS of $3.92 versus an estimate of $3.04.

Revenue was up $811.01 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.8 which was followed by a 14.78% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stock Futures Down Ahead Of Powell, PMI Data; Crude Oil Falls Sharply

By Lisa Levin
Today, 5:56 AM
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Friday after recording losses on Thursday. The Dow Jones closed lower by more than 100 points, while the Nasdaq Composite fell around 150 points in the previous session after the US Federal Reserve, on Wednesday, raised its policy rate by 75 basis points for the third time.

AIR